The knowledge of the traditional plants in India is a collection over millennia by
our ancient people. The Siddha System of Medicine (Traditional Tamil System of medicine) is
the foremost of all other medical systems in the world which provide service to the humanity
for more than 5000 years in combating diseases and also in maintaining its physical, mental
and moral health. Vitex species were used in siddha for its anti- viral activity for several years.
However, the present study deals with the Human Immunodeficiency Virus because of its
complexity and killing effects. FTIR analysis of Vitex altissima L and Vitex leucoxylon L
revealed the presence of 21 and 17 bioactive compounds respectively. These compounds were
analysed further for its binding affinity mechanism against one of the virulence causing
protein, reverse transcriptase (target protein) of Human Immunodeficiency Virus (HIV) by
using molecular docking and bioinformatics tools. Interaction rate was determined between
bioactive compounds against the protein target based on binding free energy requirements.
Molecular docking was also made to the commercially available drugs (Zidovudine,
Stavudine, and Nevirapine) against the target protein. By comparing the results between
bioactive compounds in the Vitex species and the commercially available drugs, it was clear
that the bioactive compounds were much more effective than the commercially available
drugs, thereby suitable for the treatment of AIDS. Hence, this study will form the basis for
promoting therapeutic lead molecules from the traditional plants which restore the tradition
and also eliminates the harmful side effects.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.